Phase I/IIa Dose-escalation Clinical Study of VAC-3S

Clinical trial NCT01549119 · COMPLETED

Trial details

NCT number: NCT01549119
Sponsor: InnaVirVax
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

HIV-1 Infection

Start date: 2012-02-01
Primary completion: 2013-02-01
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.